PP2A methylesterase PME‐1 suppresses anoikis and is associated with therapy relapse of PTEN‐deficient prostate cancers
Authors:
Open Access
- 18 April 2023
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 17 (6) , 1007-1023
Abstract
While organ‐confined prostate cancer (PCa) is mostly therapeutically manageable, metastatic progression of PCa remains an unmet clinical challenge. Resistance to anoikis, a form of cell death initiated by cell detachment from the surrounding extracellular matrix, is one of the cellular processes critical for PCa progression towards aggressive disease. Therefore, further understanding of anoikis regulation in PCa might provide therapeutic opportunities. Here, we discover that PCa tumours with concomitant inhibition of two tumour suppressor phosphatases, PP2A and PTEN, are particularly aggressive, having < 50% 5‐year secondary‐therapy‐free patient survival. Functionally, overexpression of PME‐1, a methylesterase for the catalytic PP2A‐C subunit, inhibits anoikis in PTEN‐deficient PCa cells. In vivo, PME‐1 inhibition increased apoptosis in in ovo PCa tumour xenografts, and attenuated PCa cell survival in zebrafish circulation. Molecularly, PME‐1‐deficient PC3 cells display increased trimethylation at lysines 9 and 27 of histone H3 (H3K9me3 and H3K27me3), a phenotype known to correlate with increased apoptosis sensitivity. In summary, our results demonstrate that PME‐1 supports anoikis resistance in PTEN‐deficient PCa cells. Clinically, these results identify PME‐1 as a candidate biomarker for a subset of particularly aggressive PTEN‐deficient PCa.Keywords
Funding Information
- Research Council of Finland (325464, 331237, 346131)
- Finnish Cancer Institute
- National Institutes of Health (R01 GM137605, R01HL082792, U54CA210184)
- National Science Foundation (CBET‐1254846, G14945R7301740)
- U.S. Department of War (BC150580)
This publication has 53 references indexed in Scilit:
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancerThe EMBO Journal, 2011
- Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic studyCancer Genetics, 2011
- Targeting anoikis resistance in prostate cancer metastasisMolecular Aspects of Medicine, 2010
- Deletion of PTEN Promotes Tumorigenic Signaling, Resistance to Anoikis, and Altered Response to Chemotherapeutic Agents in Human Mammary Epithelial CellsCancer Research, 2009
- Structural Mechanism of Demethylation and Inactivation of Protein Phosphatase 2ACell, 2008
- Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancerClinical & Experimental Metastasis, 2008
- Transparent Adult Zebrafish as a Tool for In Vivo Transplantation AnalysisCell Stem Cell, 2008
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature, 2005
- The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cellsOncogene, 1999
- Integrins and anoikisCurrent Opinion in Cell Biology, 1997